Author:
Puszkiel Alicja,Noé Gaëlle,Bellesoeur Audrey,Kramkimel Nora,Paludetto Marie-Noëlle,Thomas-Schoemann Audrey,Vidal Michel,Goldwasser François,Chatelut Etienne,Blanchet Benoit
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Pharmacology
Reference66 articles.
1. Cargnello M, Roux PP. Activation and function of the MAPKs and their substrates, the MAPK-activated protein kinases. Microbiol Mol Biol Rev. 2011;75:50–83.
2. Davies H, Bignell GR, Cox C, Stephens P, Edkins S, Clegg S, et al. Mutations of the BRAF gene in human cancer. Nature. 2002;417:949–54.
3. Long GV, Menzies AM, Nagrial AM, Haydu LE, Hamilton AL, Mann GJ, et al. Prognostic and clinicopathologic associations of oncogenic BRAF in metastatic melanoma. J Clin Oncol. 2011;29:1239–46.
4. Summary of product characteristics: Tafinlar (dabrafenib); 2013. http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Product_Information/human/002604/WC500149671.pdf . Accessed 13 Feb 2018.
5. Tafinlar FDA label; 2013. https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/202806s010lbl.pdf . Accessed 9 Jun 2018.
Cited by
81 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献